TY - JOUR
T1 - Anti-infective chemoprophylaxis after solid-organ transplantation
AU - Deziel, Paul J.
AU - Razonable, Raymund
PY - 2018/6/3
Y1 - 2018/6/3
N2 - Introduction: Solid organ transplant (SOT) recipients are at high risk of opportunistic infections due to bacterial, viral, fungal, and parasitic pathogens. Anti-infective prophylaxis is a time-tested proven strategy for the prevention of these infections after SOT. Areas covered: The current recommendations for the prevention of surgical site infections, herpes simplex, cytomegalovirus, invasive fungal infections, and selected parasitic diseases are highlighted. Recent peer-reviewed publications on the prevention of infection after SOT were reviewed and their significance was discussed in the context of the current recommendations for preventing infectious complications. Expert commentary: The authors comment on the current approaches to infection prevention in transplant recipients, and discuss how these recommendations are implemented in their clinical practice. Notable findings published during the past year were highlighted, and their clinical significance was interpreted in the context of current recommendations. The evolution of diagnostic and immunologic assays was emphasized, with focus on their potential role in optimizing the current antimicrobial approaches to infection prevention after SOT.
AB - Introduction: Solid organ transplant (SOT) recipients are at high risk of opportunistic infections due to bacterial, viral, fungal, and parasitic pathogens. Anti-infective prophylaxis is a time-tested proven strategy for the prevention of these infections after SOT. Areas covered: The current recommendations for the prevention of surgical site infections, herpes simplex, cytomegalovirus, invasive fungal infections, and selected parasitic diseases are highlighted. Recent peer-reviewed publications on the prevention of infection after SOT were reviewed and their significance was discussed in the context of the current recommendations for preventing infectious complications. Expert commentary: The authors comment on the current approaches to infection prevention in transplant recipients, and discuss how these recommendations are implemented in their clinical practice. Notable findings published during the past year were highlighted, and their clinical significance was interpreted in the context of current recommendations. The evolution of diagnostic and immunologic assays was emphasized, with focus on their potential role in optimizing the current antimicrobial approaches to infection prevention after SOT.
KW - Infection
KW - opportunistic infection
KW - prevention
KW - prophylaxis
KW - transplantation
UR - http://www.scopus.com/inward/record.url?scp=85048255778&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048255778&partnerID=8YFLogxK
U2 - 10.1080/1744666X.2018.1476852
DO - 10.1080/1744666X.2018.1476852
M3 - Review article
C2 - 29764228
AN - SCOPUS:85048255778
SN - 1744-666X
VL - 14
SP - 469
EP - 479
JO - Expert review of clinical immunology
JF - Expert review of clinical immunology
IS - 6
ER -